Denise Balingit is a Killeen, Texas based nurse practitioner. Active license number of Denise Balingit is 1201538 for Psych/Mental Health in Texas. Her current practice location is 5400 Golden Gate Dr, Killeen. Patients can reach her at 254-415-5466. Denise Balingit is MSN, APRN, PMHNP-BC and her NPI number (Unique professional ID assigned by NPPES) is 1588057921. Denise Balingit has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Denise Balingit speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1588057921
NPI Enumeration Date:
10 Mar, 2015
NPI Last Update On:
10 Jun, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Denise Balingit are as mentioned below.
License Number
Specialization
State
Status
1201538
Psych/Mental Health
Texas
Primary
761348
Registered Nurse
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Denise Balingit 5400 Golden Gate Dr, Killeen, Texas
Zip:
76549-5632
Patients can reach Denise Balingit at 5400 Golden Gate Dr, Killeen, Texas or can call to book an appointment on 254-415-5466.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.